At autopsy, a 4.5 × 3 × 3 cm protuberant mass was identified inside the trachea beneath the tracheostomy and at the site of the endotracheal tube balloon. This mass consisted of dark red granulation tissue with a fresh blood clot on the surface, from which blood could be expressed. A large amount of fresh blood was also present in the trachea, bronchi, pulmonary alveoli, esophagus and stomach. Microscopic examination of the polypoid tracheal mass showed necrotic granulation tissue composed of numerous small to medium caliber blood vessels, some with thicker walls and dilated lumens. There were innumerable fungal hyphae growing within the vessels and extending into the surrounding interstitium. These fungal hyphae were of uniform diameter with intertwined branches and numerous septae (Figure 1 ). There were no fungal hyphae demonstrated in the lung tissue itself. Examination of the bone marrow showed engraftment of the myeloid and erythroid precursors with hypocellularity. No megakaryocytes were seen. There was no evidence of residual leukemia in the bone marrow or other organs.
Homogenized tissue samples from the tracheal mass and the lung parenchyma were stained with calcofluor white and cultured for fungi using standard methods. No fungal elements were seen in either tissue preparation received in microbiology, although histologic sections of the tracheal lesion revealed fungal hyphae. After 2 weeks of incubation at 30°C, both specimens grew rare velvety black colonies with black reverses both on Sabouraud dextrose agar and Mycocel agar (Difco, Ann Arbor, MI, USA). Scotch tape hyphae were smooth-walled, septate and brown. Pale brown phialides with vase-shaped colarettes developed after 3 weeks in slide culture. These produced oval to cylindrical conidia which accumulated at the tips (Figure 2 ), pathogno-
The MIC for amphotericin B and 5-FC was defined as monic for P. verrucosa. 1 the lowest concentration that inhibited 90-100% of the visIn vitro susceptibilities for amphotericin B, itraconazole, ible growth. The MIC for the azoles was defined as the fluconazole and 5-FC against the P. verrucosa isolate were lowest concentration that inhibited 80% of visible growth. determined using the NCCLS M27-P standards in a broth
The MICs were determined in duplicate for the isolates macrodilution method for filamentous fungi. 2 using the broth macrodilution technique. Prior to MIC testing, the isolates were passaged three times on Sabouraud dextrose agar to ensure stability and viability. Prior to the second MIC determination, the isolates were again passaged twice to ensure stability of the MIC. P. verrucosa ATCC 28181 was used as the control strain.
The P. verrucosa strain recovered at autopsy remained susceptible to amphotericin B with an MIC of 0.1 g/ml (Table 1) . In conclusion, Phialophora species must be added to the richardsiae are also well described. Keratitis has also been growing list of opportunistic fungal pathogens described in described due to P. mutabilis.
5 These cases were treated BMT patients. Moreover, one must be aware that this infecwith topical clotrimazole for cutaneous disease and ketotion may develop despite prophylactic azole administration, conazole for keratomycosis, with good results.
and may have a fatal outcome despite engraftment and There has also been a single fatal case of endocarditis appropriate antifungal therapy. of a native aortic and a porcine mitral valve in a diabetic patient who presented with endophthalmitis. The causative agent was identified as P. richardsiae. 6 A single case of a
